Cargando…
Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples
Botulinum neurotoxins (BoNTs) cause the life-threatening neurological illness botulism in humans and animals and are divided into seven serotypes (BoNT/A–G), of which serotypes A, B, E, and F cause the disease in humans. BoNTs are classified as “category A” bioterrorism threat agents and are relevan...
Autores principales: | Simon, Stéphanie, Fiebig, Uwe, Liu, Yvonne, Tierney, Rob, Dano, Julie, Worbs, Sylvia, Endermann, Tanja, Nevers, Marie-Claire, Volland, Hervé, Sesardic, Dorothea, Dorner, Martin B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690110/ https://www.ncbi.nlm.nih.gov/pubmed/26703727 http://dx.doi.org/10.3390/toxins7124860 |
Ejemplares similares
-
Recommended Immunological Assays to Screen for Ricin-Containing Samples
por: Simon, Stéphanie, et al.
Publicado: (2015) -
Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test
por: Worbs, Sylvia, et al.
Publicado: (2015) -
Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test
por: Weisemann, Jasmin, et al.
Publicado: (2015) -
Is it Possible to Accurately Determine Content of Botulinum Neurotoxin Type A in Drug Products?
por: Sesardic, Dorothea
Publicado: (2012) -
Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B
por: Miethe, Sebastian, et al.
Publicado: (2016)